Medical Ethics is a commercial and development stage life science company focused on pain mitigation in wounds for humans and animals.
Through Medical Ethics’ proven, patent protected platform technology, we have identified a transformational way of mitigating pain and minimising suffering associated with wounds.
In humans, we are investing in the development of our technology for the treatment of chronic wounds such as venous leg ulcers. We have also identified future near-term opportunities for application in the treatment of traumatic wounds caused by surgical procedures and mass trauma situations such as accidents, military conflict and natural disasters.
In animals, our technology supports wound care required for surgical procedures in sheep, pigs, cattle, equine and companion animals. We are the first, and currently the only, company globally to develop, launch and commercialise a topical pain and wound management product for use in livestock undergoing painful surgical procedures, such as dehorning, tail docking, castration and fly-strike prevention.
Develop and deliver highly effective, safe, affordable and practical pain mitigation and accelerated wound healing products, to prevent pain and minimise suffering associated with wounds in humans, livestock and companion animals.
End unnecessary suffering from wound pain and accelerate the healing process.
Medical Ethics’ primary objective is to develop world leading products from our patented and commercially proven IP and to seek regulatory approvals for both humans and animals in key global markets.
The license agreements will include upfront payments milestones and royalty payments.
This model has proved successful with Medical Ethics securing two multinational pharmaceutical companies to license their technology in animals globally – Dechra Pharmacuticals and Bayer Animal Health.
Discussions have commenced with several interested parties for the distribution of our human products once market approvals have been achieved.
Co-Founder, Managing Director
Co-Founder, Chief Medical Officer
Co-Founder, Communication and Business Development Director